This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
Learn more about the Freedom of Information Act (FOIA) Reading Room, which is part of the 1996 amendments to FOIA, mandating publicly accessible "electronic reading rooms" with agency FOIA response materials and other information routinely available to the public.
Please note that files more than five years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
We found 715 items
IT Schedule 70 is the largest, most widely used acquisition vehicle in the federal government. IT Schedule 70 is an indefinite delivery/indefinite quantity (IDIQ) provide direct access to products, services and solutions.
Request for Quotation for the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP) for the August 2016 P&T Committee Meeting.
DHA has entered into a Memorandum of Understanding (MOU) with GSA as its singular Health IT procurement solution. This partnership will ensure that the creation of the Health IT SIN is a valuable resource to Federal, State, Local and Tribal Governments.
IT Schedule 70 is proposing a new Special Item Number (SIN) for Health IT to assist customer agencies in procuring Health IT services by clearly differentiating them from other IT related services currently available under the program. The new Health IT SIN will provide industry partners the opportunity to differentiate their Health IT services ...
The Director, DHA, approved the recommendations from the February 2016 DoD P&T Committee meeting on May 5, 2016, with an implementation date of August 10, 2016.
The Director, DHA, approved the recommendations from the February 2016 DoD P&T Committee meeting on May 5, 2016, with an implementation date of August 10, 2016.
The Director, DHA, approved the recommendations from the February 2016 DoD P&T Committee meeting on May 5, 2016, with an implementation date of August 10, 2016.
The Director, DHA, approved the recommendations from the February 2016 DoD P&T Committee meeting on May 5, 2016, with an implementation date of August 10, 2016.
The Director, DHA, approved the recommendations from the February 2016 DoD P&T Committee meeting on May 5, 2016, with an implementation date of August 10, 2016.
This fact sheet describes the element, Uranium, and its primary health effects.
Lists the pharmaceutical agents the DOD P&T Committee intends to evaluate at the May 2016 DOD P&T Committee meeting.
The Director, DHA, approved the recommendations from the November 2015 DoD P&T Committee meeting on January 29, 2016.
The Director, DHA, approved the recommendations from the Nov. 2015 DOD P&T Committee meeting on Jan. 29, 2016.
The Director, DHA, approved the recommendations from the Nov. 2015 DOD P&T Committee meeting on Jan. 29, 2016.
The Director, DHA, approved the recommendations from the Nov. 2015 DOD P&T Committee meeting on Jan. 29, 2016.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.